hypertension

Arterial hypertension affects approximately 1.3 billion adults globally and is the leading contributor to cardiovascular disease burden. Lifestyle modification, and pharmacological treatment with renin-angiotensin system inhibitors, calcium channel blockers, and diuretics in combination remain the pillars of management. Renal denervation and aldosterone synthase inhibitors represent emerging therapeutic approaches for resistant hypertension.